BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Anika Therapeutics 

32 Wiggins Avenue

Bedford  Massachusetts  01730   U.S.A.
Phone: 781-457-9000 Fax: 781-935-4120


SEARCH JOBS

View Clinical Trials from BioPharm Insight

Anika Therapeutics is a pioneer in developing therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body. HA enhances joint function and coats, protects, cushions and lubricates soft tissues. HA also is present in the skin, where it supports skin structure and elasticity. With more than 20 years of experience in HA technology, Anika is recognized worldwide as a provider of premium HA products that are effective, safe and long-lasting.

Anika manufactures and distributes a diverse portfolio of HA-based products that cover a broad range of therapeutic applications. These products include ORTHOVISC®, ORTHOVISC® mini, and MONOVISC™ used in the treatment of osteoarthritis; HYVISC® used in the treatment of equine osteoarthritis; the ELEVESS™ family of cosmetic dermatology products for facial wrinkles, scar remediation and lip augmentation; AMVISC®, AMVISC® Plus, STAARVISC™ II, and OPTIVISC™ injectable viscoelastic HA products for ophthalmic surgery; INCERT®, an HA-based anti-adhesive for surgical applications; and next-generation products for joint health and aesthetic dermatology based on the Company's proprietary, chemically modified HA.


 Key Statistics


Email:
Ownership: Public

Web Site: Anika Therapeutics
Employees:
Symbol: ANIK
 



Industry
Biotechnology






 Company News
Anika Therapeutics (ANIK) To Present At Canaccord Genuity 34th Annual Growth Conference 8/5/2014 9:45:32 AM
Anika Therapeutics (ANIK) Announces U.S. Commercialization Partnership For Hyalomatrix® With Wound Care Leader Medline Industries, Inc. 7/31/2014 11:24:01 AM
Anika Therapeutics (ANIK) Reports Second-Quarter 2014 Financial Results 7/31/2014 10:34:31 AM
Anika Therapeutics (ANIK) Announces U.S. Commercialization Partnership For Hyalomatrix® With Wound Care Leader Medline Industries, Inc. 7/30/2014 11:10:52 AM
Anika Therapeutics (ANIK) Announces Date Of Second-Quarter 2014 Financial Results Conference Call 7/16/2014 11:23:17 AM
Anika Therapeutics (ANIK) Reports First Quarter 2014 Financial Results 4/30/2014 8:07:33 AM
Anika Therapeutics (ANIK) Announces Date Of First-Quarter 2014 Financial Results Conference Call 4/17/2014 6:50:23 AM
Anika Therapeutics (ANIK) Announces First U.S. Commercial Sale Of Monovisc® 4/16/2014 9:23:07 AM
Anika Therapeutics (ANIK) Announces Dismissal Of MONOVISC® U.S. Patent Infringement Lawsuit 3/13/2014 8:01:23 AM
Anika Therapeutics (ANIK) To Present At Canaccord Genuity Musculoskeletal Conference March 11 3/5/2014 7:27:06 AM
12345678910...